Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avinger Inc (AVGR)

Avinger Inc (AVGR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,734
  • Shares Outstanding, K 16,813
  • Annual Sales, $ 9,130 K
  • Annual Income, $ -19,450 K
  • 60-Month Beta 1.56
  • Price/Sales 0.88
  • Price/Cash Flow N/A
  • Price/Book 0.71
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.55
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.40
  • Growth Rate Est. (year over year) +71,457.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3100 +41.52%
on 03/19/20
0.6700 -34.52%
on 03/05/20
-0.1716 (-28.12%)
since 02/28/20
3-Month
0.3100 +41.52%
on 03/19/20
1.3203 -66.77%
on 01/09/20
-0.7013 (-61.52%)
since 12/27/19
52-Week
0.3100 +41.52%
on 03/19/20
12.6000 -96.52%
on 04/10/19
-9.1243 (-95.41%)
since 03/29/19

Most Recent Stories

More News
Avinger Reports Fourth Quarter 2019 Financial Results

Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral...

AVGR : 0.4387 (-4.63%)
Avinger, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 5, 2020 / Avinger, Inc. (AVGR) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 5, 2020 at 4:30 PM Eastern Time....

AVGR : 0.4387 (-4.63%)
Avinger to Announce Fourth Quarter 2019 Financial Results on March 5, 2020

REDWOOD CITY, CA / ACCESSWIRE / February 27, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

AVGR : 0.4387 (-4.63%)
Avinger Announces Publication of SCAN Clinical Study in Peer-Reviewed Journal

OCT Imaging with Pantheris Superior or Equivalent to IVUS on all Parameters

AVGR : 0.4387 (-4.63%)
Avinger's Pantheris Featured in Live Case Transmission at LINC 2020

REDWOOD, CA / ACCESSWIRE / February 4, 2020 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

AVGR : 0.4387 (-4.63%)
Avinger Closes $4.5 Million Equity Offering

REDWOOD CITY, CA / ACCESSWIRE / January 31, 2020 / Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten...

AVGR : 0.4387 (-4.63%)
Avinger Announces the Passing of Director Donald A. Lucas

REDWOOD CITY, CA / ACCESSWIRE / January 30, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

AVGR : 0.4387 (-4.63%)
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock

REDWOOD CITY, CA / ACCESSWIRE / January 28, 2020 / Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of an underwritten...

AVGR : 0.4387 (-4.63%)
Avinger Enrolls First Patient in IMAGE-BTK Clinical Study Evaluating Safety and Efficacy Endpoints for Pantheris SV

Post-Market Study Intended to Support Commercial Expansion of Small Vessel Image-Guided Atherectomy Device

AVGR : 0.4387 (-4.63%)
Avinger Announces Successful First Procedures in Europe with Ocelaris Chronic Total Occlusion (CTO) Image-Guided Crossing Device

REDWOOD CITY, CA / ACCESSWIRE / January 9, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

AVGR : 0.4387 (-4.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AVGR with:

Business Summary

Avinger, Inc. is engaged in designing, manufacturing and selling image-guided, catheter-based systems to treat peripheral arterial disease. The company's product consists of Lightbox imaging console, Wildcat, Kittycat, Ocelot, Ocelot PIXL, Ocelot MVRX and Juicebox. Avinger, Inc. is based in Redwood City,...

See More

Key Turning Points

2nd Resistance Point 0.5062
1st Resistance Point 0.4724
Last Price 0.4387
1st Support Level 0.4125
2nd Support Level 0.3864

See More

52-Week High 12.6000
Fibonacci 61.8% 7.9052
Fibonacci 50% 6.4550
Fibonacci 38.2% 5.0048
Last Price 0.4387
52-Week Low 0.3100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar